Heres how your semaglutide patient journey might look: Consultation At your initial consultation, well take some standard measurements such as height, weight, and BMI to form a foundation for your weight loss goals
Beyond glycemic control, GLP-1 receptor agonists exert several additional effects that contribute to their therapeutic profile
Further reading and references Wilding et al: Once-Weekly Semaglutide in Adults with Overweight or Obesity Moiz et al: Long-Term Efficacy and Safety of Once-Weekly Semaglutide for Weight Loss in Patients Without Diabetes Rubino et al: Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial Bolek et al: Effect of semaglutide with metformin for weight loss and fertility in polycystic ovary syndrome (PCOS) patients with obesity About the authorView full bio Dr Nienke Lees Women's Health Service Lead MB BChir, MA, MRCS(ENT), DOHNS, MRCGP, LMCA Dr Nienke Lees is the Women's Health Service Lead at Genwell
Large observational studies have reported that GLP-1 RA use is associated with a 2330% reduction in CRC risk [18, 19]
Ozeki, Y., Masaki, T., Kamata, A., Miyamoto, S., Yoshida, Y., Okamoto, M., Gotoh, K., & Shibata, H
Counterfeit inner needle cover has a blue transparent color